Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 3/20 | 0.37 |
| ▸ | CA12 | O43570 | 4/20 | 0.35 |
| ▸ | CA1 | P00915 | 4/20 | 0.35 |
| ▸ | CA2 | P00918 | 4/20 | 0.35 |
| ▸ | CA4 | P22748 | 4/20 | 0.35 |
| ▸ | CA9 | Q16790 | 4/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | GLP1R | P43220 | 8/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TTR | P02766 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31297097 | 0.88 | MEN1 (0.38) | CRBNCA12CA1CA2CA4 | |
| SCHEMBL26133563 | 0.88 | NOS3 (0.41) | CRBNCA12CA1CA2CA4 | |
| SCHEMBL26133569 | 0.88 | NOS3 (0.41) | CRBNCA12CA1CA2CA4 | |
| SCHEMBL18886281 | 0.87 | CRBN (0.41) | CRBNCA12CA1CA2CA4 | |
| SCHEMBL17282361 | 0.87 | CRBN (0.41) | CRBNCA12CA1CA2CA4 | |
| SCHEMBL25189070 | 0.86 | CRBN (0.36) | CRBNCA12CA1CA2CA4 | |
| SCHEMBL13892548 | 0.84 | CRBN (0.38) | CRBNCA12CA1CA2CA4 | |
| SCHEMBL22541320 | 0.83 | CA2 (0.39) | CRBNCA12CA1CA2CA4 | |
| SCHEMBL19138454 | 0.83 | CA2 (0.39) | CRBNCA12CA1CA2CA4 | |
| SCHEMBL25431966 | 0.82 | GLP1R (0.45) | CRBNMEN1KMT2AGLP1RTTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4651902-A2 | ASGPR BINDING COMPOUNDS AND CONJUGATES | Lycia Therapeutics, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| WO-2024155747-A2 | ASGPR BINDING COMPOUNDS AND CONJUGATES | LYCIA THERAPEUTICS, INC. (US) | 2024-07-25 | — | — | WO | disclosed |